The US FDA’s New Rule for Regulating Laboratory-Developed Tests
This Viewpoint discusses potential benefits and obstacles regarding US Food and Drug Administration (FDA) oversight of laboratory-developed tests.
Authors
- Daniel Aaron (ORCID: https://orcid.org/0000-0003-4490-7504)
- I. Glenn Cohen (ORCID: https://orcid.org/0000-0002-0223-3305)
- Eli Y. Adashi (ORCID: https://orcid.org/0000-0001-7730-1192)
Institutions
- Harvard University (US)
- University of Utah (US)
- Brown University (US)
- Harvard University Press (US)
Publication Details
- Journal
- JAMA Health Forum
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1001/jamahealthforum.2024.2917
- Citations
- 8
- Primary Topic
- Biomedical Ethics and Regulation
- Type
- article
- Field-Weighted Citation Impact
- 2.61